These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3133841)

  • 1. Cryoprecipitate revisited.
    Aledort LM
    Transfusion; 1988; 28(4):295-6. PubMed ID: 3133841
    [No Abstract]   [Full Text] [Related]  

  • 2. Cryoprecipitate: uses and alternatives.
    Poon MC
    Transfus Med Rev; 1993 Jul; 7(3):180-92. PubMed ID: 8347984
    [No Abstract]   [Full Text] [Related]  

  • 3. 1-Deamino-8-D-arginine vasopressin and cryoprecipitate in variant von Willebrand disease.
    Hanna WT; Slywka J; Dent J; Ruggeri ZM; Zimmerman TS
    Am J Hematol; 1985 Oct; 20(2):169-73. PubMed ID: 3929596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryoprecipitate for uremic bleeding.
    Davenport R
    Clin Pharm; 1991 Jun; 10(6):429. PubMed ID: 1905991
    [No Abstract]   [Full Text] [Related]  

  • 5. Current concepts in the management of hemophilia.
    Karayalcin G
    Pediatr Ann; 1985 Sep; 14(9):640-2, 644-5, 648-53 passim. PubMed ID: 3932946
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment with plasma concentrates in hemophilia A. State Security and Health Planning Office. Expert Panel].
    Sangre (Barc); 1994 Apr; 39(2):157-61. PubMed ID: 8059299
    [No Abstract]   [Full Text] [Related]  

  • 7. T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates.
    Menitove JE; Aster RH; Casper JT; Lauer SJ; Gottschall JL; Williams JE; Gill JC; Wheeler DV; Piaskowski V; Kirchner P; Montgomery RR
    N Engl J Med; 1983 Jan; 308(2):83-6. PubMed ID: 6401196
    [No Abstract]   [Full Text] [Related]  

  • 8. DDAVP and cryoprecipitate in mild haemophilia.
    Boulton FE; Smith A
    Lancet; 1979 Sep; 2(8141):535. PubMed ID: 90263
    [No Abstract]   [Full Text] [Related]  

  • 9. Cryoprecipitate: all in the family?
    Kasper CK
    JAMA; 1984 Nov; 252(19):2755-6. PubMed ID: 6436521
    [No Abstract]   [Full Text] [Related]  

  • 10. AIDS and preventive treatment in hemophilia.
    Desforges JF
    N Engl J Med; 1983 Jan; 308(2):94-5. PubMed ID: 6216409
    [No Abstract]   [Full Text] [Related]  

  • 11. The efficacy and safety of cryoprecipitate in the treatment of acquired hypofibrinogenaemia.
    Idris SF; Hadjinicolaou AV; Sweeney M; Winthrop C; Balendran G; Besser M
    Br J Haematol; 2014 Aug; 166(3):458-61. PubMed ID: 24725203
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidence of infectious and noninfectious side effects in hemophilia patients in the new German Federal States during treatment with cryoprecipitate.
    Lenk H; Schneider M
    Semin Thromb Hemost; 2002 Apr; 28 Suppl 1():51-6. PubMed ID: 12016579
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of DDAVP and cryoprecipitate in mild to moderate haemophilia A and von Willebrand's disease.
    Berry EW
    Prog Clin Biol Res; 1990; 324():269-78. PubMed ID: 2106689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryoprecipitate: a safe factor VIII replacement.
    Kletzel M; Charlton R; Becton D; Berry DH
    Lancet; 1987 May; 1(8541):1093-4. PubMed ID: 2883430
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Do not Do' Recommendations in Hemophilia.
    De la Corte-Rodriguez H; Rodriguez-Merchan EC; Alvarez-Roman MT; Martin-Salces M; Jimenez-Yuste V
    Cardiovasc Hematol Disord Drug Targets; 2020; 20(3):168-174. PubMed ID: 32133968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some aspects on the management of hemophilia.
    Aledort LM
    Thromb Haemost; 1995 Jul; 74(1):440-3. PubMed ID: 8578502
    [No Abstract]   [Full Text] [Related]  

  • 18. Normal T-cell subset ratios in patients with severe haemophilia A treated with cryoprecipitate.
    Rasi VP; Koistinen JL; Lohman CM; Silvennoinen OJ
    Lancet; 1984 Feb; 1(8374):461. PubMed ID: 6142197
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of von Willebrand's Disease.
    Mannucci PM
    N Engl J Med; 2004 Aug; 351(7):683-94. PubMed ID: 15306670
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemostatic effect of deamino-8-D-arginine vasopressin (DDAVP) in hemophilia A and von Willebrand's disease].
    Fukui H; Takase T
    Rinsho Ketsueki; 1985 Jul; 26(7):1069-79. PubMed ID: 3932720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.